Michael R. Stenger, MD :: Nationwide Children’s Hospital, Columbus, Ohio

Michael R. Stenger, MD

Michael R. Stenger, MD

Neonatology
Physician Team

Neonatology Fellowship
Faculty

Contact Information

Neonatology
700 Children's Dr
Columbus, OH 43205 [ map ]
PH: (614) 722-4559
FX: (614) 722-4541

Biography

Michael Stenger, MD, is a member of the Section of Neonatology at Nationwide Children’s Hospital, an investigator in the Center for Perinatal Research at The Research Institute at Nationwide Children’s Hospital and a Clinical Assistant Professor of Pediatrics at The Ohio State University College of Medicine. The primary focus of Dr. Stenger’s research is the role of nitric oxide and hyperoxia on lung growth and development. On the one hand, NO can combine with oxygen to form nitrogen dioxide (NO2) or with superoxide to form the potent oxidant peroxynitrite, both of which have been shown to cause lung injury. In contrast, NO may also act as an antioxidant and may protect against cellular damage and cytotoxicity caused by reactive oxygen species. Currently, a newborn mouse model is used while future studies will involve human samples such as tracheal aspirates to evaluate the impact of nitric oxide on lung growth and development.

Gender:

  • Male

Languages Spoken:

  • English

Education and Training

Medical School

  • University of Kentucky College of Medicine
    Date Completed: 05/19/2001

Residency

  • Nationwide Children's Hospital
    Date Completed: 06/30/2004

Fellowship

  • Nationwide Children's Hospital
    Date Completed: 06/30/2007

Department:

  • Pediatrics

Section:

  • Neonatology

Specialty:

  • Neonatal-Perinatal Medicine
  • Pediatrics

Date of Appointment at Nationwide Children’s Hospital:

  • 07/01/2007

Publications

  • Jadcherla,Sudarshan,R; Slaughter,Jonathan,L; Stenger,Michael,R; Klebanoff,Mark; Kelleher,Kelly; Gardner,William. 2013. Practice Variance, Prevalence, and Economic Burden of Premature Infants Diagnosed With GERD.  Hospital pediatrics. Vol. 3, no. 4. (October): 335-341.
  • Slaughter,Jonathan,L; Stenger,Michael,R; Reagan,Patricia,B. 2013. Variation in the Use of Diuretic Therapy for Infants With Bronchopulmonary Dysplasia.  PEDIATRICS. Vol. 131, no. 4. (April): 716-723.
  • Stenger,Michael,R; Slaughter,Jonathan,L; Kelleher,Kelly; Shepherd,Edward,G; Klebanoff,Mark,A; Reagan,Patricia; Nelin,Leif,D; Gardner,William. 2012. Hospital Variation in Nitric Oxide Use for Premature Infants.  PEDIATRICS. Vol. 129, no. 4. (April): E945-E951.
  • Chicoine,Louis,G; Stenger,Michael,R; Cui,Hongmei; Calvert,Andrea; Evans,Rebecca,J; English,B,Keith; Liu,Yusen; Nelin,Leif,D. 2011. Nitric oxide suppression of cellular proliferation depends on cationic amino acid transporter activity in cytokine-stimulated pulmonary endothelial cells.  American journal of physiology. Lung cellular and molecular physiology. Vol. 300, no. 4. (April): L596-604.
  • Chicione,Louis,G; Stenger,Michael,R; Cui,Hongmei; Calvert,Andrea; Evans,Rebecca,J; English,B,Keith; Liu,Yusen; Nelin,Leif,D. 2011. Nitric oxide suppression of cellular proliferation depends on cationic amino acid transporter activity in cytokine-stimulated pulmonary endothelial cells.  AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY. Vol. 300, no. 4. (April): L596-L604.
  • Stenger,Michael,R; Reber,Kristina,M; Giannone,Peter,J; Nankervis,Craig,A. 2011. Probiotics and prebiotics for the prevention of necrotizing enterocolitis.  Current infectious disease reports. Vol. 13, no. 1. (February): 13-20.
  • Chicoine LG, Stenger MR, Cui H, Calvert A, Evans RJ, English BK, Liu Y, Nelin LD. 2011. Nitric oxide suppression of cellular proliferation depends on cationic amino acid transporter activity in cytokine-stimulated pulmonary endothelial cells.  Am J Physiol Lung Cell Mol Physiol. Vol. 300, no. 4. (January): L596-L604.
  • Stenger MR, Reber KM, Giannone PJ, Nankervis CA. 2011. Probiotics and prebiotics for the prevention of necrotizing enterocolitis.  Curr Infect Dis Rep. Vol. 13, no. 1. (January): 13-20.
  • Stenger MR, Rose MJ, Joshi MS, Rogers LK, Chicoine LG, Bauer JA, Nelin LD. 2010. Inhaled nitric oxide prevents 3-nitrotyrsoine formation in the lungs of neonatal mice exposed to > 95% oxygen.  Lung. Vol. 188, no. 3. (January): 217-227.
  • Rose MJ, Stenger MR, Joshi MS, Welty SE, Bauer JA, Nelin LD. 2010. Inhaled nitric oxide decreases leukocyte trafficking in the neonatal mouse lung during exposure to >95% oxygen.  Pediatr Res. Vol. 67, no. 3. (January): 244-249.
  • Nelin LD, DT Malleske, MR Stenger, and LG Chicoine. 2007. Vascular arginase and hypertension.  Current Hypertension Reviews. Vol. 3, no. January: 242-249.
  • Singh PK, Jones MM, Lane JE, Nesset A, Zimmerman LJ, Ribeiro-Rodrigues R, Richter A, Stenger MR, Carter CE. 1997. Synthesis and in vitro trypanocidal activity of some novel iron chelating agents.  Arzneimittelforschung. Vol. 47, no. January: 311-315.
  • Nelin LD, Stenger MR, Malleske DT, Chicoine LG. Vascular arginase and hypertension. Current Hypertension Reviews 3: 242-249, 2007.
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000